essential hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with hypertension who are treated with ARB other than candesartan. Their blood pressure levels evaluated by ABPM do not achieve the goal of Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009).
Exclusion criteria
Exclusion criteria: 1. secondary hypertension 2. systolic blood pressure >160 mmHg and or diastolic blood pressure > 100 mmHg 3. malignant hypertension 4. history of stroke, myocardial infarction and other cardiovascular disease that needed hospitalization within recent 6 months. 5. atrial fibrillation 6. patients with fundal hemorrhage, exudation or papilledema due to hypertensive retinopathy 7. liver dysfunction(the levels of AST or ALT reached 250% of their upper normal limit.) 8. Renal dysfunction (serum creatinine > 2.0 mg/dl) 9. hyperkalemia (serum K > 5.5 mEq/l) 10. pregnant or nursing women 11. patients who are not recommended for participation in this study by physician in charge with medical reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference of mean nocturnal blood pressure between candesartan and other angiotensin 2 receptor blockers. | — |
Secondary
| Measure | Time frame |
|---|---|
| The difference of mean 24-hour blood pressure between candesartan and other angiotensin 2 receptor blockers. The difference of mean morning blood pressure between candesartan and other angiotensin 2 receptor blockers. Percentage of the patient who achieved the target of 24-hour blood pressure in Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). | — |
Countries
Japan
Contacts
Ehime University Graduate School of Medicine Department of Integrated Medicine and Informatics